Skip to main content
. 2015 Jun 5;5(6):e007527. doi: 10.1136/bmjopen-2014-007527

Table 4.

Incremental BCVA letters gained at 6 months versus laser therapy alone (random treatment effects model)

Treatment Incremental letters gained vs laser photocoagulation alone
Ranibizumab 0.5 mg PRN 11.5 (7.5 to 15.9)*
Ranibizumab 0.5 mg PRN+laser photocoagulation 10.1 (5.1 to 15.3)*
Dexamethasone 0.7 mg implant 3.5 (−1.6 to 9.1)
Aflibercept 2q4 10.2 (4.6 to 15.5)*
Sham 1.0 (–3.5 to 5.9)

*p<0.05.

Studies included in the base case analysis are VIBRANT,12 BRAVO,9 BRIGHTER,32 COMRADE-B,33 Tan et al,27 Battaglia Parodi et al,8 GENEVA.14

2q4, 2 mg monthly; BCVA, best corrected visual acuity; PRN, pro re nata (as needed).